Here are this week’s top five most-clicked stories from MHA’s News Roundup newsletter.
Fighting Measles Is Expensive. See What It Cost to Contain 10 Cases.
The Washington Post, by Naema Ahmed, Lena H. Sun, and Aaron Steckelberg
Half a million dollars. That’s about how much it costs for several public health agencies to contain one small measles outbreak in the Denver area this year. Measles is the most contagious vaccine-preventable disease, and time is of the essence to contain the spread. In Colorado, dozens of investigators traced patient movements, checked vaccination records, and quarantined people at risk while also examining how often air circulated through a medical clinic.
Sinai Hospital Creates Guidebook to Better Serve Observant Jews
Jewish Times, by Andrew Guckes
Sinai Hospital has created a 24-page guide to help staff better support observant Jewish patients and families, covering practices related to the Sabbath, kosher food, prayer, holidays, and other religious needs. The effort also includes a new walking route and process for Sabbath-observant patients coming to the emergency department, reflecting Sinai’s longstanding connection with Baltimore’s Jewish community.
Johns Hopkins, WellSpan Extend Cancer Care Partnership
Chief Healthcare Executive, by Ron Southwick
Johns Hopkins Medicine and WellSpan Health formed a partnership to expand cancer care nearly a decade ago, and that collaboration is poised to continue. Kevin Sowers, president of the Johns Hopkins Health System and executive vice president of Johns Hopkins Medicine, and Roxanna Gapstur, president and CEO of WellSpan Health, said they are looking forward to extending their partnership on cancer care services.
1 CEO, Multiple Hospitals: The Math Behind Fewer C-Suite Roles
Becker’s Hospital Review, by Kristin Kuchno
Health systems are increasingly consolidating hospital CEO roles, with existing executives taking responsibility for multiple hospitals or entire markets rather than replacing departing leaders. The shift is intended to improve operational efficiency, coordination and consistency across systems, though some organizations continue to maintain or create individual executive roles.
Managing Ocular Adverse Effects Associated with Antibody-Drug Conjugates
Oncology Nurse Advisor, by Jennifer Larson
Targeted anticancer agents known as antibody-drug conjugates (ADCs) have opened new possibilities for effective treatment in a variety of cancer types. When examining a patient who is undergoing treatment with an ADC, Sarah Sunshine, M.D., an ophthalmologist at the University of Maryland Medical Center who sees patients at the University of Maryland Greenebaum Comprehensive Cancer Center, looks for specific symptoms.